2025 Oncology Institute
April 19, 2025 | 7:25 PM EST
- Home
- Clinical Resources Search
- PQI in Action: Multidisciplinary Management of Metastatic Colorectal Cancer Patients within Medically Integrated Pharmacy Practices
Multidisciplinary Management of Metastatic Colorectal Cancer Patients within Medically Integrated Pharmacy Practices
Download PQI pdf 2.88MB
Last Updated: November 1, 2019
By: Alabama Oncology, AL | Nebraska Cancer Specialists, NE
About this PQI in Action
The PQI in Action incorporates opinions and experiences from oncology experts within the medically integrated teams at both Nebraska Cancer Specialists (NCS) and Alabama Oncology (ALO). Both cancer treatment centers have successfully implemented medically integrated pharmacies (MIP) as well as the use of Positive Quality Interventions throughout their care teams to improve the clinical outcomes of patients receiving regorafenib for treatment of metastatic colorectal cancer.
More About This PQI in Action
Find a PQIPQI in Action
PQI in Action: Medically Integrated Dispensing of Regorafenib for Metastatic Colorectal Cancer Patients
Last Updated: June 1, 2020
PQI
PQI: Regorafenib (Stivarga®) in the Treatment of Hepatocellular Carcinoma
Last Updated: October 13, 2023
PQI
PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)
Last Updated: October 10, 2023